During our analysis of breast cancer cell lines for subpopulations with the CD44+/CD24- phenotype, we observed that almost all cell lines with a CD44+/CD24- subpopulation were basal breast cancer cells that had undergone epithelial to mesenchymal transition (EMT) [21]. This evidence concerns the gene CD44 and breast cancer.